Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furukawa, H.
Right arrow Articles by Yasuda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furukawa, H.
Right arrow Articles by Yasuda, T.

Annals of Surgical Oncology, Vol 4, Issue 3 209-214, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Extended surgery--left upper abdominal exenteration plus Appleby's method--for type 4 gastric carcinoma

H. Furukawa, M. Hiratsuka, T. Iwanaga, S. Imaoka, O. Ishikawa, T. Kabuto, Y. Sasaki, M. Kameyama, H. Ohigashi, S. Nakamori and T. Yasuda
Department of Surgery, Center for Adult Diseases, Osaka, Japan.

BACKGROUND: The prognosis after surgical treatment for type 4 gastric cancer, including linitis plastica, remains poor. The most frequent recurrence mode is retroperitoneal involvement. To remove the tumor and microinvasion surrounding the stomach, extended surgery, left upper abdominal exenteration plus the Appleby's method (LUAE + Apl), has been performed for type 4 cancers since 1983. PATIENTS AND METHODS: A total of 54 patients with type 4 cancer underwent extended surgery (LUAE + Apl) over the past 11 years. In the LUAE + Apl surgical procedure, the whole stomach, pancreas body and tail, spleen, gallbladder, transverse colon, and left adrenal were removed en bloc. The results of this treatment are reported and the most beneficial application of this procedure (group A) is evaluated and compared with findings in similar patients who underwent common surgery between 1973 and 1983 (group B). RESULTS: As postoperative complications, pancreatic fistula (30%; control 19%), liver dysfunction (15%; 14%), anastomosis failure (6%; 9%), and infection (4%; 1%) were observed (NS). In group A, one patient died of liver dysfunction and another of multiple organ failure due to major pancreatic fistula. In stage III, the 5-year survival rate of group A (40%) was better than that of group B (20%; p < 0.05). In stage IV, the 5-year survival rate of group A (5%; 3% in group B) was not improved. CONCLUSION: LUAE + Apl improved the survival of patients with scirrhous cancer in stage III, but it was not effective for those in stage IV. To improve the survival of patients in stage IV, a new concept of treatment and supportive therapy needs to be used.


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
T. Yamao, K. Ohta, S. Ohyama, S. Ishihara, K. Chin, M. Maruyama, T. Takahashi, and T. Nakajima
A Preliminary Study of Preoperative Chemotherapy Combining Irinotecan and Cisplatin in Patients with Gastric Cancer with Unresectable Para-aortic Lymph Node Metastases
Jpn. J. Clin. Oncol., May 1, 2004; 34(5): 255 - 261.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M Falconi and P Pederzoli
The relevance of gastrointestinal fistulae in clinical practice: a review
Gut, December 1, 2001; 49(90004): iv2 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Qual Saf Health CareHome page
A Melville, A Eastwood, E Morris, and D Forman
Management of upper gastrointestinal cancers
Qual. Saf. Health Care, March 1, 2001; 10(1): 57 - 64.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society of Surgical Oncology.